Skip to content

Public FDA record

Z-0927-06: Product is Optetrak Cemented Finned Tibial Tray Sz. 4F/5T. Knee prosthesis. Product is labeled in part:

Recall record Z-0927-06 for Exactech, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0927-06
Company in FDA record
Exactech, Inc.
FDA classification date
Jun 2, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

An implant within a lot of finned tibial trays manufactured at Exactech was not made to specification. The locking cavity in the tibial tray was not fully machined thus preventing the tibial insert from locking in place.

Source facts

Action
Each consignee contacted by mail 12/19/2005, and asked to return the product to Exactech. The returned product will be quarantined and evaluated.
Initiated
2005-12-19
Root cause
Other
Terminated
2012-06-29
Distribution
Distributed domestically to Alabama and Louisiana, and internationally to Spain, Germany and Greece.
Recall number
Z-0927-06
Recall status
Terminated
CDRH record ID
43488
FDA classified
2006-06-02
Recall event number
34294

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗